John Federspiel - Net Worth and Insider Trading

John Federspiel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Federspiel owns 1 companies in total, including Interpace Biosciences Inc (IDXG) .

Click here to see the complete history of John Federspiel’s form 4 insider trades.

Insider Ownership Summary of John Federspiel

Ticker Comapny Transaction Date Type of Owner
IDXG Interpace Biosciences Inc 2003-12-31 director

John Federspiel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John Federspiel Ownership Network

Ownership Network List of John Federspiel

No Data

Ownership Network Relation of John Federspiel

Insider Network Chart

John Federspiel Owned Company Details

What does Interpace Biosciences Inc do?

Who are the key executives at Interpace Biosciences Inc?

John Federspiel is the director of Interpace Biosciences Inc. Other key executives at Interpace Biosciences Inc include Principal Financial Officer Christopher Mccarthy , director & President and CEO Thomas W. Burnell , and 10 percent owner Peter H Kamin .

Interpace Biosciences Inc (IDXG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Interpace Biosciences Inc (IDXG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Interpace Biosciences Inc (IDXG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Interpace Biosciences Inc (IDXG)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Interpace Biosciences Inc Insider Transactions

No Available Data

John Federspiel Mailing Address

Above is the net worth, insider trading, and ownership report for John Federspiel. You might contact John Federspiel via mailing address: C/o Pdi, Inc., Saddle River Exec Centre, 1 Rt 17 South, Saddle River Nj 07458.

Discussions on John Federspiel

No discussions yet.